Loss-of-function mutation in Omicron variants reduces spike protein expression and attenuates SARS-CoV-2 infection
Covid19-Sources
Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection
Thread by @JadeKhalife on Thread Reader App
🔴 tohmes on Twitter
Behavioral manipulation-key to the successful global spread of the new coronavirus SARS-CoV-2? - PubMed
Selective Neuronal Mitochondrial Targeting in SARS-CoV-2 Infection Affects Cognitive Processes to Induce 'Brain Fog' and Results in Behavioral Changes that Favor Viral Survival - PubMed
Long COVID: pathophysiological factors and abnormalities of coagulation
Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial
Outpatient Treatment of COVID-19 and the Development of Long COVID Over 10 Months: A Multi-Center, Quadruple-Blind, Parallel Group Randomized Phase 3 Trial
Effectiveness of BNT162b2 Vaccine against Omicron Variant Infection among Children 5-11 Years of Age, Israel - PubMed
SARS-CoV-2 Abwassermonitoring in Bayern - Bay-VOC
Post-COVID-19 related osteonecrosis of the jaw (PC-RONJ): an alarming morbidity in COVID-19 surviving patients - BMC Infectious Diseases
Avascular osteonecrosis after treatment of SARS: a 3-year longitudinal study
Autonomic Dysfunction related to Post-Acute SARS-CoV-2 Syndrome
Influenza A viral infection associated with acute renal failure - PubMed
Physio-metabolic and clinical consequences of wearing face masks—Systematic review with meta-analysis and comprehensive evaluation
Durability of Bivalent Boosters against Omicron Subvariants
Autoantibody production is enhanced after mild SARS-CoV-2 infection despite vaccination in patients with and without long COVID
How a rural school teacher became a top COVID sleuth
Condition-Dependent and Dynamic Impacts of Indoor Masking Policies for COVID-19 Mitigation: A Nationwide, Interrupted Time-Series Analysis
Symptom persistence and biomarkers in post-COVID-19/chronic fatigue syndrome - results from a prospective observational cohort
Resia Pretorius on Twitter
Covid-19 and post-acute sick leave: a hybrid register and questionnaire study in the adult Danish population
Jan Hartmann on Twitter
Ralf Wittenbrink on Twitter
Severe Maternal Morbidity and Mortality of Pregnant Patients With COVID-19 Infection
Pregnant patients with COVID-19 infection at delivery were more likely to develop severe maternal morbidity compared with those without (46.4 vs 18.8 per 1000, adjusted odds ratio [aOR]: 2.60 [95% CI, 2.39-2.82]) (Table 2). Among the individual morbidity indicators, COVID-19 infection was associated with the following outcomes with all aORs greater than 2: increased risk of tracheostomy, respiratory distress syndrome, ventilation, acute myocardial infarction, sepsis, shock, cardiac arrest, and coagulopathy (Table 2).
The mortality risk of pregnant patients with COVID-19 infection at delivery was approximately 14 times higher compared with those without (64.0 vs 4.3 per 100 000 deliveries; aOR, 13.91 [95% CI, 6.36-30.42] (Table 2). Failure-to-rescue risk following the development of severe maternal morbidity was also increased in pregnant patients with COVID-19 infection at delivery (1.5% vs 0.2%; aOR, 5.56 [95% CI, 2.51-12.30]).
Among the pregnant patients with COVID-19 infection who died during the hospital admission, the median time-to-death was 16 days, but this was particularly short in the early period (median 6 days in April to June 2020). The COVID-19 case-fatality rate decreased over time from 232.9 to 79.1 per 100 000 deliveries (P for trend < .001).
Monatlicher Krankenstand der Versicherten der Betriebskrankenkassen
Detection of viable SARS-CoV-2 in retrospective analysis of aerosol samples collected from hospital rooms of patients with COVID-19
SARS-CoV-2 infection weakens immune-cell response to vaccination